Abstract:Background: The number of blood vessels correlates with metastasis in solid tumors, including oral squamous cell carcinoma (OSCC). Hypoxia inducible factor-1alpha (HIF-1 alpha) could play a role in tumor lymphangiogenesis by regulating the lymphatic expression of vascular endothelial growth factor-C (VEGF-C). HIF-1 alpha protein expression, VEGF-C protein expression, lymphatic vessel density (LVD) and blood vessel density (BVD) in OSCC were investigated. Materials and Methods: HIF-1 alpha and VEGF-C protein expression were investigated by means of immunohistochemistry in samples from 65 cases of OSCC. The density of the lymphatic microvessels and blood microvessels immunohistochemically stained by LYVE-1 and CD34 antibody, respectively, was calculated. The association between the HIF-1 alpha expression and the clinicopathological parameters was evaluated. Results: HIF-1 alpha overexpression occurred in 43 out of the 65 tumor samples (66.2%), while VEGF-C overexpression was observed in 34 out of the 65 tumor samples (52.3%). Higher LVD was found in both high HIF-1 alpha and high VEGF-C expression cases. HIF-1 alpha overexpression was significantly correlated with VEGF-C overexpression (p=0.018, Chi-square test), higher LVD (p < 0.001, Mann-Whitney U-test), and regional lymph nodal involvement (p=0.004, Chi-square test) as well as UICC TMN classification (p=0.043, Chi-square test), respectively. In addition, higher BVD existed in the high HIF-1 alpha and VEGF-C expression groups (p < 0.001, Mann-Whitney U-test). Conclusion: HIF-1 alpha might play a crucial role in regional lymph node metastasis as a regulator of lymphangiogenesis and angiogenesis in OSCC with a possible novel pathway involving VEGF-C. Therefore, HIF-1 alpha might be a particularly promising target for controlling regional lymph node metastases by a combination of anti-angiogenic and anti-lymphangiogenic effects in OSCC.

Expression of HIF-1α and Its Relationship with Angiogenesis in Osteosarcoma

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Relationship of the Expression of HIF-1α and GLUT-1 with Angiogenesis in Osteosarcoma

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

Relationship of the expression of iNOS and HIF-1α with angiogenesis in osteosarcoma

Overexpression of Hypoxia-Inducible Factor-1 Alpha in Human Osteosarcoma: Correlation with Clinicopathological Parameters and Survival Outcome

[Effect of Silencing HIF-1alpha by RNA Interference on Expression of Vascular Endothelial Growth Factor in Osteosarcoma Cell Line SaOS-2 under Hypoxia].

Expression and Significance of Hypoxemia-Inducible Factor-1 Alpha in Osteosarcoma of the Jaws

Expression of Hypoxia-Inducible Factor 1α in Osteosarcoma and Its Value in Predicting Chemosensitivity

Expression and significance of hypoxia inducible factor-1α in osseous sarcoma of jaws

Effects of Sirna-Mediated HIF-1α Gene Silencing on Angiogenesis in Osteosarcoma.

Relation Between the Expression of Hypoxia Inducible Factor-1Α and Angiogenesis in Ovarian Cancer Using Tissue Microarray

Expression of VEGF and PCNA and Microvessel Density in Osteosarcoma

Expressions and implication of MMP-9 and VEGF in osteosarcoma

Experimental Study of the Correlation Between Hypoxia Inducible Factor-1α and Microvessel Density in S180 Sarcoma

Hypoxia-Inducible Factor-1 Expression Predicts Osteosarcoma Patients’ Survival: A Meta-Analysis

Expression of survivin and its relationship with vascular endothelial cell growth factor in osteosarcoma

Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells

Hypoxia Inducible Factor-Alpha Expression Correlates with Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis/angiogenesis in Oral Squamous Cell Carcinoma.

The expression of hypoxia-inducible factor 1alpha (HIF-1α) and cyclooxygenase 2 (COX-2) and the correlation with angiogenesis in human lung cancer

HIF-1α Expression Correlates with VEGF-C Expression and Lymphangiogenesis in OSCC